Working Hard or Hardly Working? Regulatory Bottlenecks in Developing a COVID-19 Vaccine

Vaccine solutions rarely reach the public until after an outbreak abates; an Ebola vaccine was approved 5 years after peak outbreak and SARS, MERS, and Zika vaccines are still in clinical development. Despite massive leaps forward in rapid science, other regulatory bottlenecks are hamstringing the g...

Descripción completa

Detalles Bibliográficos
Autores principales: Pregelj, Lisette, Hine, Damian C., Oyola-Lozada, Maria G., Munro, Trent P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2020
Materias:
Science & Society
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7293492/
https://www.ncbi.nlm.nih.gov/pubmed/32600777
http://dx.doi.org/10.1016/j.tibtech.2020.06.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7293492/
https://www.ncbi.nlm.nih.gov/pubmed/32600777
http://dx.doi.org/10.1016/j.tibtech.2020.06.004

Ejemplares similares